NorthWest Biotherapeutics Inc (NWBO)

[meirluc]

Regardless of Dr. Liau's misstatement that 90% of the original
placebos crossed over, all those sloppy authors had to do was
to look at the JAMA article graph that presented the post
progression survival times of all the crossovers and there were
only 64 such patients in the trial.

Even if at the end of the trial, only about 92 of the original
99 placebos were left ( about 7 dropped out?), the 64 crossovers
barely comprised 70% of those 92 original placebos, not 90%.

Instead of revising the article by correcting only one of
several outrageous errors, the entire article should have been
withdrawn.